Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -12.02 % |
3 Month Return | -8.5 % |
1 Year Return | -59.2 % |
Market Stats | |
Previous Close | ₹3.66 |
Open | ₹3.74 |
Volume | 4.54L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹14.64Cr |
P/E Ratio | 183 |
PEG Ratio | -7320 |
Market Cap | ₹14.64 Cr |
P/B Ratio | 5.75 |
EPS | 0.14 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 7.02 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹14.64 Cr | 31.55% | 0.70 | -₹1 Cr | ₹27 Cr | |
BUY | ₹8,805.97 Cr | 4.56% | 0.50 | ₹135 Cr | ₹498 Cr | |
NA | ₹156.91 Cr | -2.6% | 0.64 | ₹9 Cr | ₹131 Cr | |
NA | ₹671.30 Cr | 440.91% | 0.54 | ₹23 Cr | ₹164 Cr | |
NA | ₹319.85 Cr | 168.38% | 1.27 | NA | NA |
Organisation | Vivanza Biosciences Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Vivanza Biosciences Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 59.95% to 60.13% in Sep 2024 quarter
Revenue Rich
Revenue is up for the last 2 quarters, 2.44 Cr → 3.0 Cr (in ₹), with an average increase of 18.7% per quarter
Promoter Holding Down
Promoters have decreased holdings from 40.05% to 39.86% in Sep 2024 quarter
Price Dip
In the last 7 days, Vivanza Biosci. stock has moved down by -5.2%
Profit Down
Netprofit is down for the last 2 quarters, 0.27 Cr → 0.02 Cr (in ₹), with an average decrease of 92.6% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 39.86% | ||
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 60.13% | 0.30 | |
Others | 0% | 0.00 |
Vivanza Biosciences Ltd in the last 5 years
Lowest (-15423.93x)
December 21, 2022
Industry (57.42x)
December 4, 2024
Today (183.00x)
December 4, 2024
Highest (884.71x)
July 19, 2023
Vivanza Biosciences Ltd’s net profit fell -92.31% since last year same period to ₹0.02Cr in the Q2 2024-2025. On a quarterly growth basis, Vivanza Biosciences Ltd has generated -92.59% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Vivanza Biosciences Ltd is currently in a Bearish trading position according to technical analysis indicators.
Vivanza Biosciences Ltd (530057) share price today is ₹3.54
Vivanza Biosciences Ltd is not listed on NSE
Vivanza Biosciences Ltd is listed on BSE
PE Ratio of Vivanza Biosciences Ltd is 183
PE ratio = Vivanza Biosciences Ltd Market price per share / Vivanza Biosciences Ltd Earnings per share
Today’s traded volume of Vivanza Biosciences Ltd(530057) is 4.54L.
Today’s market capitalisation of Vivanza Biosciences Ltd(530057) is ₹14.64Cr.
Vivanza Biosciences Ltd(530057 | Price |
---|---|
52 Week High | ₹11.72 |
52 Week Low | ₹3.36 |
Vivanza Biosciences Ltd(530057) share price is ₹3.54. It is down -69.80% from its 52 Week High price of ₹11.72
Vivanza Biosciences Ltd(530057) share price is ₹3.54. It is up 5.36% from its 52 Week Low price of ₹3.36
Vivanza Biosciences Ltd(530057 | Returns |
---|---|
1 Day Returns | -0.12% |
1 Month Returns | -12.02% |
3 Month Returns | -8.5% |
1 Year Returns | -59.2% |